Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more

Active pharmaceutical substances require an International Nonproprietary Name (INN) assigned by the World Health Organization (WHO) to obtain market authorization as a medicinal product. INNs are selected to represent a unique, generic name for a drug enabling unambiguous identification by stakehold...

Descripción completa

Detalles Bibliográficos
Autores principales: Parren, Paul W. H. I., Carter, Paul J., Plückthun, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590622/
https://www.ncbi.nlm.nih.gov/pubmed/28621572
http://dx.doi.org/10.1080/19420862.2017.1341029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590622/
https://www.ncbi.nlm.nih.gov/pubmed/28621572
http://dx.doi.org/10.1080/19420862.2017.1341029

Ejemplares similares